BIotech sector seems to be starting a new bullish phase

AMEX:ARKG   ARK Genomic Revolution ETF
According to the CEO of NVDA, the next big revolution is coming into biotech. Biology will be engineered and therefore will compound exponentially. Now might be a good time to enter this field.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.